Status:

COMPLETED

Clinical Study to Examine the Effects of Erythropoietin on Left Ventricular Function After Acute Myocardial Infarction

Lead Sponsor:

University Medical Center Groningen

Collaborating Sponsors:

The Interuniversity Cardiology Institute of the Netherlands

Janssen-Cilag Ltd.

Conditions:

Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The primary objective of this study is to establish the effects of a single bolus of EPO, administered within three hours after a primary PCI for a first acute myocardial infarction, on left ventricul...

Detailed Description

Erythropoetin (EPO) is commonly known as an effective treatment for anemia. However, several important extra-hematopoeitic effects of EPO are suggested which might be beneficial in the setting of an a...

Eligibility Criteria

Inclusion

  • Successful primary PCI (TIMI 2/3) for a first acute myocardial infarction, diagnosed by:
  • chest pain suggestive for acute myocardial infarction
  • symptom onset \< 12 hour before hospital admission, or \< 24 hour in case ongoing ischemia
  • ECG with ST-T segment elevation \> 1 mV in 2 or more leads
  • TIMI flow 0/1 before primary PCI on diagnostic coronary angiography;

Exclusion

  • Hemoglobin levels \> 10.6 mmol/L;
  • Anticipated additional revascularisation within 4 months;
  • Cardiogenic shock;
  • Presence of other serious medical conditions
  • Pregnancy/breast feeding
  • Malignant hypertension
  • End stage renal failure (creatinin \> 220 micromol/l)
  • Previous treatment with rh-EPO
  • Blood transfusion \<12 weeks prior to randomisation
  • Polycythemia vera
  • Previous acute myocardial infarction
  • Concomitant inflammatory or malignant disease
  • Recent trauma or major surgery
  • Unwilling to sign informed consent
  • Atrial fibrillation

Key Trial Info

Start Date :

January 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2009

Estimated Enrollment :

529 Patients enrolled

Trial Details

Trial ID

NCT00449488

Start Date

January 1 2007

End Date

October 1 2009

Last Update

December 15 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Medical Center Groningen

Groningen, Provincie Groningen, Netherlands, 9700RB